Clearmind Medicine Inc. Common Shares share price logo

Clearmind Medicine Inc. Common Shares Share Price

NASDAQ: CMND

Small Cap

$0.83

+0.01

(+0.88%)

as on

Clearmind Medicine Inc. Common Shares Stock Performance

as on April 23, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.71
    $0.90
    downward going graph

    14.46%

    Downside

    8.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.59
    $52.40
    downward going graph

    29.46%

    Downside

    6213.25%

    Upside

    downward going graph

Clearmind Medicine Inc. Common Shares share price movements today

Previous Close
$0.82
Open
$0.74
Volume
3.7M
Day's Low - High
$0.71 - $0.90
52 Week Low - High
$0.59 - $52.40

Clearmind Medicine Inc. Common Shares Historical Returns

1 Month Return
+ 24.24 %
3 Month Return
-69.63 %
1 Year Return
-97.95 %
3 Year Return
-99.89 %
5 Year Return
0 %

Clearmind Medicine Inc. Common Shares Stock Fundamentals & Key Indicators

Check Clearmind Medicine Inc. Common Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-119.72%

Clearmind Medicine Inc. Common Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Clearmind Medicine Inc. Common Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Clearmind Medicine Inc. Common Shares image
Clearmind Medicine Inc. Common Shares
NA$2.7MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.2B123.87%131.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.1B102.14%28.532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.5BNA128.255.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B52.39%18.0531.41%

Stock Returns calculator for Clearmind Medicine Inc. Common Shares Stock including INR - Dollar returns

The Clearmind Medicine Inc. Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Clearmind Medicine Inc. Common Shares investment value today

Current value as on today

₹2,284

Returns

-₹97,716

(-97.72%)

Returns from Clearmind Medicine Inc. Common Shares Stock

-₹97,925 (-97.92%)

Dollar Impact

₹209 (+0.21%)

Clearmind Medicine Inc. Common Shares Stock’s Investor Sentiment and Interest

Investment in Clearmind Medicine Inc. Common Shares Shares on INDmoney has grown by 1266.66% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:1266.66% versus previous 30 day period

Search interest for Clearmind Medicine Inc. Common Shares Stock has increased by 1153% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1153% versus previous 30 day period

Clearmind Medicine Inc. Common Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
0
Operating Income
-
-1
-1
-2
-2
-2
-1
-1
-2
-3
EBITDA
-
-1
-1
-2
-1
-1
-1
-1
0
-3
Interest Expense
-
0
-
0
0
0
0
0
0
0
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-
-1
-1
-2
-1
-1
-1
-1
0
-3
Income Tax Expense
-
0
0
0
0
0
0
0
0
0
Net Income
-4
-1
0
-2
0
-1
-1
-1
0
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Clearmind Medicine Inc. Common Shares Annual Profit & Loss

All numbers in Millions USD

Oct 2020
Dec 2020
Oct 2021
Dec 2021
Oct 2022
Dec 2022
Oct 2023
Dec 2023
Oct 2024
Oct 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
0
-
0
-
0
-
0
0
Operating Income
0
-
-3
-
-9
-
-8
-
-7
-5
EBITDA
0
-
-3
-
-9
-
-11
-
-6
-3
Interest Expense
-
-
0
-
0
-
0
-
0
0
Depreciation
-
-
0
-
0
-
0
-
0
0
Income Before Tax
0
-
-3
-
-9
-
-11
-
-6
-3
Income Tax Expense
0
-
0
-
0
-
0
-
0
0
Net Income
0
0
-2
-3
-7
-6
-8
-8
-5
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Clearmind Medicine Inc. Common Shares Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-1
-1
-2
-1
-1
-1
-1
0
-3
Operating Cash Flow
-1
-1
-1
-1
-1
-1
-1
-1
-2
Investing Cash Flow
-
0
0
0
0
0
0
0
-
Financing Cash Flow
7
0
0
0
0
0
0
3
7
Change in Cash
5
-1
0
-1
-1
-1
-1
0
5

Clearmind Medicine Inc. Common Shares Annual Cash Flow

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Oct 2020
Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
0
0
0
0
-2
-9
-8
-7
-3
Operating Cash Flow
0
0
0
0
-2
-5
-6
-6
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
5
0
11
8
2
Change in Cash
0
0
0
0
3
-4
5
1
-2

Global Institutional Holdings in Clearmind Medicine Inc. Common Shares

Funds
Holdings
AdvisorShares Investments, LLC
0.01%
TWO SIGMA SECURITIES, LLC
0%
XTX Topco Ltd
0%
Virtu Financial LLC
0.04%
Citadel Advisors Llc
0%
See all

Insights on Clearmind Medicine Inc. Common Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 47.4% return, outperforming this stock by 147.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.5% return, outperforming this stock by 125.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, CMND stock has moved down by -70.1%

About Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post-traumatic stress disorder and other health conditions; Polyrizon Ltd. to develop novel intranasal MEAI formulation; and NeuroThera Labs Inc. to develop a therapy for weight loss and Metabolic Dysfunction-Associated Steatotic Liver Disease. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
OrganisationClearmind Medicine Inc. Common Shares
Headquarters1220 West 6th Avenue, Vancouver, BC, Canada, V6H 1A5
IndustryBiotechnology
CEODr. Adi Zuloff-Shani Ph.D.
E-voting on sharesClick here to vote

Key Management of Clearmind Medicine Inc. Common Shares

Name

Title

Ms. Mylene Touboul

Accounting Manager

Ms. Mary-Elizabeth Gifford

Chief of Global Impact

Ms. Adi Varon

Controller

Dr. Adi Zuloff-Shani Ph.D.

Chief Executive Officer

Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPA

Chief Financial Officer

Prof. Mark Haden M.S.W.

Vice President of Business Development

FAQs

What is Clearmind Medicine Inc. Common Shares share price today?

Clearmind Medicine Inc. Common Shares share price today is $0.83 as on at the close of the market. Clearmind Medicine Inc. Common Shares share today touched a day high of $0.9 and a low of $0.71.

What is the 52 week high and 52 week low for Clearmind Medicine Inc. Common Shares share?

Clearmind Medicine Inc. Common Shares share touched a 52 week high of $52.4 on and a 52 week low of $0.59 on . Clearmind Medicine Inc. Common Shares stock price today i.e. is closed at $0.83,which is 98.42% down from its 52 week high and 41.76% up from its 52 week low.

What is Clearmind Medicine Inc. Common Shares's market capitalisation today?

Clearmind Medicine Inc. Common Shares market capitalisation is $0.00T as on .

How to invest in Clearmind Medicine Inc. Common Shares Stock (CMND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Clearmind Medicine Inc. Common Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clearmind Medicine Inc. Common Shares Shares that will get you 1.8072 shares as per Clearmind Medicine Inc. Common Shares share price of $0.83 per share as on April 23, 2026 at 1:29 am IST.

What is the minimum amount required to buy Clearmind Medicine Inc. Common Shares Stock (CMND) from India?

Indian investors can start investing in Clearmind Medicine Inc. Common Shares (CMND) shares with as little as ₹93.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Clearmind Medicine Inc. Common Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on Clearmind Medicine Inc. Common Shares share’s latest price of $0.83 as on April 23, 2026 at 1:29 am IST, you will get 12.0482 shares of Clearmind Medicine Inc. Common Shares. Learn more about fractional shares .